Cardiopulmonary complications of ergot-derivative dopamine agonists
Rack, M.J.; Baran, A.Sinan.; Richert, A.C.; Roffwarg, H.P.
Journal of Clinical Psychiatry 65(10): 1429-30; Author Reply 1430
2004
ISSN/ISBN: 0160-6689 PMID: 15491249 Document Number: 566763
Document emailed within 1 workday
Related Documents
Rasmussen, V.G.; Poulsen, S.H.; Dupont, E.; Østergaard, K.; Safikhany, G.; Egeblad, H. 2009: Heart abnormalities in Parkinson patients after discontinuation or continuation of ergot-derived dopamine agonists: a treatment-blinded echocardiographic study Journal of Heart Valve Disease 18(4): 463-469Robbers, J.E.; Jones, L.G.; Krupinski, V.M. 1974: Ergot physiology. the production of ergot alkaloids in saprophytic culture by a homokaryotic strain of ergot Lloydia 37(1): 108-111
Hoffman, W.; Rostock, A.; Siegemund, C.; Bartsch, R. 1989: AWD 52-39, an ergot derivative with potential nootropic activity Activitas Nervosa Superior 31(1): 56-57
Calne, D.B.; Shoulson, I.; Kartzinel, R. 1976: An ergot derivative in the treatment of Parkinson's disease Postgraduate Medical Journal 52suppl 1: 81-85
Tadori, Y.; Kobayashi, H. 2014: The therapeutic plasma concentrations of antiparkinson dopamine agonists and their in vitro pharmacology at dopamine receptors Nihon Shinkei Seishin Yakurigaku Zasshi 34(5-6): 127-132
Kohli, J.D.; Weder, A.B.; Goldberg, L.I.; Ginos, J.Z. 1980: Structure activity relationships of N-substituted dopamine derivatives as agonists of the dopamine vascular and other cardiovascular receptors Journal of Pharmacology and Experimental Therapeutics 213(2): 370-374
Breese, G.R.; Baumeister, A.A.; McCown, T.J.; Emerick, S.G.; Frye, G.D.; Crotty, K.; Mueller, R.A. 1984: Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine Journal of Pharmacology and Experimental Therapeutics 231(2): 343-354
Vickers, A.E.; Connors, S.; Zollinger, M.; Biggi, W.A.; Larrauri, A.; Vogelaar, J.P.; Brendel, K. 1993: The biotransformation of the ergot derivative CQA 206-291 in human, dog, and rat liver slice cultures and prediction of in vivo plasma clearance Drug Metabolism and Disposition: the Biological Fate of Chemicals 21(3): 454-459
Hoffmann, I.S.; Talmaciu, R.K.; Cubeddu, L.X. 1986: Interactions between endogenous dopamine and dopamine agonists at release modulatory receptors: multiple effects of neuronal uptake inhibitors on transmitter release Journal of Pharmacology and Experimental Therapeutics 238(2): 437-446
Cahn, J.; Borzeix, M.G. 1983: Cerebral blood flow and metabolism, and neurologic deficit in an experimental infarction. Application to the study of an ergot derivative Presse Medicale 12(48): 3058-3060
Pirtosek, Z.; Flisar, D. 2004: Neuroprotection and dopamine agonists Advances in Experimental Medicine and Biology 541: 55-74
Heins, J.R. 1997: New dopamine agonists on the horizon South Dakota Journal of Medicine 50(7): 239-240
Mao, Y-sheng.; He, J.; Yan, S-ping.; Cheng, G-yu.; Sun, K-lin.; Liu, X-yang.; Fang, D-kang.; Li, J.; Wang, Y-gang.; Huang, J-feng. 2012: Role of conventional pulmonary function tests and cardiopulmonary exercise test in the prediction of postoperative cardiopulmonary complications in high risk thoracic cancer patients Zhonghua Zhong Liu Za Zhi 34(1): 51-56
Desjars, P.; Meignier, M.; Pinaud, M.; Tasseau, F.; Nicolas, F. 1981: Sodium nitroprusside in ischaemic complications of acute ergot poisoning La Nouvelle Presse Medicale 10(36): 2959-2961
Teräväinen, H.; Calne, S.; Burton, K.; Beckman, J.; Calne, D.B. 1988: Efficacy of dopamine agonists in dystonia Advances in Neurology 50: 571-578
Kohli, J.D. 1990: Dopamine receptor agonists and antagonists Proceedings of the Western Pharmacology Society 33: 21-27
Zarifian, E. 1979: Dopa and dopamine agonists in depression L'Encephale 5(5 Suppl): 665-670
Girbes, A.R.; van Veldhuisen, D.J.; Smit, A.J. 1991: Dopamine agonists, a new perspective in cardiovascular therapy? Netherlands Journal of Medicine 39(1-2): 65-71
Gekht, A.B. 2002: Use of dopamine agonists in the treatment of Parkinson's disease Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 102(9): 54-58
Aramideh, M.; de Weerd, A.W. 2006: The restless legs syndrome can be treated with dopamine agonists Nederlands Tijdschrift Voor Geneeskunde 150(40): 2173-2177